Mohhamad Rafi Khezri

16PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineInnate immunityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 31, 2026
The interplay between circadian rhythm components and apoptosis in health and disease.

Mohammad Rafi Khezri, Somayeh Mohammadi Panah, Morteza Ghasemnejad-Berenji

|Apr 15, 2025
The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice.

Mohammad Ebrahim Abbaszadeh, Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji

|Sep 03, 2024
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.

Hemin Ashayeri Ahmadabad, Somayeh Mohammadi Panah, Hojat Ghasemnejad-Berenji

|Feb 09, 2024
The interplay between the PI3K/AKT pathway and circadian clock in physiologic and cancer-related pathologic conditions.

Mohammad Rafi Khezri, Hsiang-Yin Hsueh, Somayeh Mohammadipanah

|Nov 03, 2023
The pharmacological effects of Berberine and its therapeutic potential in different diseases: Role of the phosphatidylinositol 3-kinase/AKT signaling pathway.

Mohammad Rafi Khezri, Somayeh Mohammadipanah, Morteza Ghasemnejad-Berenji

Pageof 3